LAVA Therapeutics NV
NASDAQ:LVTX

Watchlist Manager
LAVA Therapeutics NV Logo
LAVA Therapeutics NV
NASDAQ:LVTX
Watchlist
Price: 1.29 USD -1.53% Market Closed
Market Cap: 33.9m USD

Wall Street
Price Targets

LVTX Price Targets Summary
LAVA Therapeutics NV

Wall Street analysts forecast LVTX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for LVTX is 1.87 USD with a low forecast of 1.01 USD and a high forecast of 3.15 USD.

Lowest
Price Target
1.01 USD
22% Downside
Average
Price Target
1.87 USD
45% Upside
Highest
Price Target
3.15 USD
144% Upside
LAVA Therapeutics NV Competitors:
Price Targets
PTGX
Protagonist Therapeutics Inc
40% Upside
MDXG
MiMedx Group Inc
92% Upside
TNG
Transgene SA
77% Upside
ORY
Oryzon Genomics SA
165% Upside
NTRA
Natera Inc
27% Upside
MRNA
Moderna Inc
77% Upside
ABBV
Abbvie Inc
16% Upside

Revenue
Forecast

Revenue Estimate
LAVA Therapeutics NV

For the last 4 years the compound annual growth rate for LAVA Therapeutics NV's revenue is 36%.

36%
Past Growth
N/A
Estimated Growth
Estimates Accuracy
5%
Average Beat

Operating Income
Forecast

Operating Income Estimate
LAVA Therapeutics NV

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
1%
Average Beat

Net Income
Forecast

Net Income Estimate
LAVA Therapeutics NV

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-11%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is LVTX's stock price target?
Price Target
1.87 USD

According to Wall Street analysts, the average 1-year price target for LVTX is 1.87 USD with a low forecast of 1.01 USD and a high forecast of 3.15 USD.

Back to Top